Our governance structure is designed to ensure vigilant oversight of our management and operations while protecting our independence as a national blood operator entrusted with maintaining a safe, secure supply of blood and blood products.

Supporting this structure is a comprehensive set of practices aimed at providing safe and high quality products and services for transfusion and transplantation patients. We engage with diverse stakeholders in Canada’s health systems, as well as in the scientific and medical communities, patient organizations, equity-deserving groups and other communities across Canada.